Viewing data from:

INDAPAMIDE

ANDA

INDAPAMIDE | A074722 | ACTAVIS ELIZABETH LLC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.1113

per ea

Lowest NADAC/Unit

$0.1072

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00228257111INDAPAMIDE 2.5 MG TABLET	$0.1113	EA	Generic	—	2026-06-17
00228257196INDAPAMIDE 2.5 MG TABLET	$0.1113	EA	Generic	—	2026-06-17
00228259711INDAPAMIDE 1.25 MG TABLET	$0.1072	EA	Generic	—	2026-06-17
00228259796INDAPAMIDE 1.25 MG TABLET	$0.1072	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$11.30

Highest Price

$354.21

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00228-2571-11INDAPAMIDE 2.5MG TAB	$11.60	FSS	AvKare, LLC	06/14/2028
00228-2571-96INDAPAMIDE 2.5MG TAB	$354.21	FSS	AvKare, LLC	06/14/2028
00228-2597-11INDAPAMIDE 1.25MG TAB	$11.30	FSS	AvKare, LLC	06/14/2028
00228-2597-96INDAPAMIDE 1.25MG TAB	$279.11	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs4 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPAINDAPAMIDE

DMF 90261991

QUIMICA SINTETICA SAINDAPAMIDE

DMF 90641991

INDUSTRIALE CHIMICA SRLINDAPAMIDE

DMF 216632008

BIOPHORE INDIA PHARMACEUTICALS PVT LTDINDAPAMIDE

DMF 386092023

ORIL INDUSTRIEInactiveINDAPAMIDE

DMF 85771990

FINE CHEMICALS CORPInactiveINDAPAMIDE

DMF 91491991

IPCA LABORATORIES LTDInactiveINDAPAMIDE USP

DMF 219752008

DISHMAN PHARMACEUTICALS AND CHEMICALS LTDInactiveINDAPAMIDE

DMF 223882009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 1.25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 17, 1996

No patent or exclusivity listings for this strength.

#002 — 2.5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 17, 1996